Salivary inflammatory biomarkers and glycated haemoglobin among patients with type 2 diabetic mellitus

BMC Oral Health

Table 3 Salivary levels of CRP, IL-6, TNF-α and HbA1C in Type 2 Diabetics and healthy controls

Salivary biomarkers	Mean	Standard deviation	Median	Interquartile range	Test Statistics	p-value
Salivary biomarkers	Mean	Standard deviation	Median	(Q₃–Q₁)	Test Statistics	p-value
CRP (μg/ml)
Controls	0.02	0.02	0.01	(0.021–0.001) = 0.02
Diabetics	0.05	0.04	0.04	(0.062–0.023) = 0.04	− 4.938*	< 0.0001
IL-6 (pg/ml)
Controls	41.94	16.88	48	(53.50–26.0) = 27.5	− 1.2828**	0.2036
Diabetics	47.2	18.49	50	(60.0–28.0) = 32.0
TNF α (pg/ml)
Controls	1.51	3.66	0.13	(0.215–0.108) = 0.11	− 2.100*	0.0357
Diabetics	5.39	12.1	0.2	(3.661–0.122) = 3.54
HbA1c (%)
Controls	4.79	0.65	4.6	(5.10–4.35) = 0.75	− 6.327*	< 0.0001
Diabetics	7.34	2.02	6.9	(9.40–5.60) = 3.80

ISSN: 1472-6831